Predictive power of the grace score in population with diabetes
Anna Baeza-Román1, Eva de Miguel-Balsa1, Jaime Latour-Pérez1
1Intensive Care Unit, Hospital General Universitario de Elche, Elche, Spain.
Insights
The GRACE score effectively predicts hospital mortality in acute coronary syndrome (ACS) patients, including those with diabetes mellitus (DM). Adding DM to the GRACE score did not improve its predictive accuracy.
Area of Science:
- Cardiology
- Clinical Risk Stratification
- Diabetes Mellitus Research
Background:
- Clinical guidelines advocate risk stratification for acute coronary syndrome (ACS) patients upon hospital admission.
- Diabetes mellitus (DM) is a known independent predictor of mortality in ACS patients but is not currently incorporated into the GRACE risk score.
Purpose of the Study:
- To validate the GRACE risk score in a contemporary ACS population.
- To specifically evaluate the GRACE score's performance in diabetic patients.
- To assess the impact of including diabetes mellitus as a variable in the GRACE risk score model.
Main Methods:
- Retrospective cohort study utilizing the ARIAM-SEMICYUC registry.
- Analysis of in-hospital mortality data for ACS patients.
- Evaluation of GRACE score predictive power using ROC curve analysis and calibration assessment.
- Assessment of the effect of DM inclusion via net reclassification improvement.
Main Results:
- The GRACE score demonstrated good predictive power for hospital mortality in the study cohort.
- Moderate calibration was observed for the GRACE score, with no significant variations across ACS types or DM status.
- Incorporating diabetes mellitus as a variable did not enhance the predictive value of the GRACE model.
Conclusions:
- The GRACE risk score exhibits appropriate predictive power and good calibration for ACS patients.
- The GRACE score is clinically applicable to the subgroup of patients with diabetes mellitus.
- Adding diabetes mellitus to the GRACE score did not provide additional predictive benefit.
Introduction:
Current clinical practice guidelines recommend risk stratification in patients with acute coronary syndrome (ACS) upon admission to hospital. Diabetes mellitus (DM) is widely recognized as an independent predictor of mortality in these patients, although it is not included in the GRACE risk score.
Objectives:
The objective of this study is to validate the GRACE risk score in a contemporary population and particularly in the subgroup of patients with diabetes, and to test the effects of including the DM variable in the model.
Material And Methods:
Retrospective cohort study in patients included in the ARIAM-SEMICYUC registry, with a diagnosis of ACS and with available in-hospital mortality data. We tested the predictive power of the GRACE score, calculating the area under the ROC curve. We assessed the calibration of the score and the predictive ability based on type of ACS and the presence of DM. Finally, we evaluated the effect of including the DM variable in the model by calculating the net reclassification improvement.
Results:
The GRACE score shows good predictive power for hospital mortality in the study population, with a moderate degree of calibration and no significant differences based on ACS type or the presence of DM. Including DM as a variable did not add any predictive value to the GRACE model.
Conclusions:
The GRACE score has an appropriate predictive power, with good calibration and clinical applicability in the subgroup of diabetic patients.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Regression Toward the Mean
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...


